HSS study identifies risk factors for “long-haul” COVID-19 in people with rheumatic diseases

 

https://www.eurekalert.org/news-releases/934062

 

 News Release 6-Nov-2021
Reports and Proceedings
Hospital for Special Surgery

 

A new study by researchers at Hospital for Special Surgery (HSS) in New York City demonstrates over half of patients with rheumatic diseases who contracted COVID-19 during the pandemic and completed a COVID-19 survey, experienced so-called “long-haul” COVID, or prolonged symptoms of the infection, including loss of taste or smell, muscle aches and difficulty concentrating, for one month or longer.

Findings identified long-haul COVID was particularly high for smokers, patients with comorbidities such as asthma or lung disease, cancer, chronic kidney disease, diabetes, congestive heart failure or myocardial infarction, and those taking corticosteroids.

-----